Net sales of diabetes medicines of Novo Nordisk in Greater China 2022, by type
In 2022, the Danish pharmaceutical company Novo Nordisk reported that its diabetes care drugs had generated over 15.2 billion Danish kroner in Greater China. Founded in 1923, the firm specializes in producing diabetes medications. Novo Nordisk's business in mainland China accounted for around ten percent of its total net sales in 2022.